Almac Group is a pharmaceutical manufacturing company based in Craigavon, Northern Ireland.
COVID-19
Almac's clinical services division participated in administering the Phase III clinical trial for Pfizer and BioNTech's COVID-19 vaccine candidate, BNT162b2.[1]
Organization
Almac has provided funding for the American Statistical Association.[2]
External links
Campbell, J. (2020, November 11). NI pharma firm Almac’s role in Covid-19 vaccine. BBC News. http://archive.today/2023.04.25-180909/https://www.bbc.com/news/uk-northern-ireland-54902978 ↩︎
ASA Organizational Members. American Statistical Association. Retrieved May 29, 2023, from https://web.archive.org/web/20230529193058/https://ww2.amstat.org/membership/corporatesupporters.cfm ↩︎
